Claudins and gastric cancer: an overview

I Hashimoto, T Oshima - Cancers, 2022 - mdpi.com
Simple Summary Gastric cancer (GC) is one of the most common cancers and the third
leading cause of cancer deaths worldwide, with a high frequency of recurrence and …

Claudin-4: a new molecular target for epithelial cancer therapy

R Fujiwara-Tani, S Mori, R Ogata, R Sasaki… - International Journal of …, 2023 - mdpi.com
Claudin-4 (CLDN4) is a key component of tight junctions (TJs) in epithelial cells. CLDN4 is
overexpressed in many epithelial malignancies and correlates with cancer progression …

TGF-β induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-α/NF-κB signal pathway

T Yan, Y Tan, G Deng, Z Sun, B Liu, Y Wang… - Cell Death & …, 2022 - nature.com
Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor.
The unregulated expression of Claudin-4 (CLDN4) plays an important role in tumor …

Context-dependent roles of claudins in tumorigenesis

J Li - Frontiers in Oncology, 2021 - frontiersin.org
The barrier and fence functions of the claudin protein family are fundamental to tissue
integrity and human health. Increasing evidence has linked claudins to signal transduction …

[HTML][HTML] Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma

V Mashayekhi, O Mocellin, MHAM Fens, GC Krijger… - Theranostics, 2021 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal types of cancer due to the
relatively late diagnosis and the limited therapeutic options. Current treatment regimens …

Targeting claudin‐4 enhances chemosensitivity in breast cancer

Y Luo, S Kishi, T Sasaki, H Ohmori… - Cancer …, 2020 - Wiley Online Library
Triple negative breast cancer (TNBC) is characterized by highly aggressive phenotype,
limited treatment options and a poor prognosis. In the present study, we examined the …

Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer

F Maesaka, M Kuwada, S Horii, S Kishi… - International Journal of …, 2022 - mdpi.com
The tight junction (TJ) protein claudin-4 (CLDN4) is overexpressed in bladder urothelial
carcinoma (BUC) and correlates with cancer progression. However, the mechanism of …

[HTML][HTML] Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas

C Nakashima, K Yamamoto, S Kishi, T Sasaki… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Abstract Claudin (CLDN)-4 expression has been associated with malignancy in various
cancers. When CLDN4 expression was examined in oral squamous cell carcinoma (OSCC) …

Role of nuclear claudin-4 in renal cell carcinoma

T Owari, T Sasaki, K Fujii, R Fujiwara-Tani… - International Journal of …, 2020 - mdpi.com
Claudin-4 (CLDN4) is a tight junction protein to maintain the cancer microenvironment. We
recently reported the role of the CLDN4 not forming tight junction in the induction of …

CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway

J Luo, H Wang, H Chen, G Gan… - Experimental …, 2020 - Wiley Online Library
New Findings What is the central question of this study? What is the influence of the
interaction between the matrix protein CLDN4 and the PI3K/Akt signalling pathway on …